2,2-difluoro-N-[(2R,3S)-1-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;2,2-difluoro-N-[(3S)-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;1-[(4-fluorophenyl)methyl]-5-iodoindazole;methanamine
C55H52F6IN9O4 — CID 158350406
Data last refreshed: (MolForge compound catalog, from PubChem)
About 2,2-difluoro-N-[(2R,3S)-1-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;2,2-difluoro-N-[(3S)-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;1-[(4-fluorophenyl)methyl]-5-iodoindazole;methanamine
2,2-difluoro-N-[(2R,3S)-1-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;2,2-difluoro-N-[(3S)-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;1-[(4-fluorophenyl)methyl]-5-iodoindazole;methanamine (PubChem CID 158350406) has the molecular formula C55H52F6IN9O4 and a molecular weight of 1143.97 g/mol. Its IUPAC name is 2,2-difluoro-N-[(2R,3S)-1-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;2,2-difluoro-N-[(3S)-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;1-[(4-fluorophenyl)methyl]-5-iodoindazole;methanamine.
Molecular Properties
| Compound Name | 2,2-difluoro-N-[(2R,3S)-1-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;2,2-difluoro-N-[(3S)-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;1-[(4-fluorophenyl)methyl]-5-iodoindazole;methanamine |
|---|---|
| PubChem CID | 158350406 |
| Molecular Formula | C55H52F6IN9O4 |
| Molecular Weight | 1143.97 g/mol |
| Exact Mass | 1143.31 |
| IUPAC Name | 2,2-difluoro-N-[(2R,3S)-1-[1-[(4-fluorophenyl)methyl]indazol-5-yl]-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;2,2-difluoro-N-[(3S)-5-oxo-2-phenylpyrrolidin-3-yl]propanamide;1-[(4-fluorophenyl)methyl]-5-iodoindazole;methanamine |
| SMILES | CC(F)(F)C(=O)N[C@H]1CC(=O)N(c2ccc3c(cnn3Cc3ccc(F)cc3)c2)[C@@H]1c1ccccc1.CC(F)(F)C(=O)N[C@H]1CC(=O)NC1c1ccccc1.CN.Fc1ccc(Cn2ncc3cc(I)ccc32)cc1 |
| InChI | InChI=1S/C27H23F3N4O2.C14H10FIN2.C13H14F2N2O2.CH5N/c1-27(29,30)26(36)32-22-14-24(35)34(25(22)18-5-3-2-4-6-18)21-11-12-23-19(13-21)15-31-33(23)16-17-7-9-20(28)10-8-17;15-12-3-1-10(2-4-12)9-18-14-6-5-13(16)7-11(14)8-17-18;1-13(14,15)12(19)16-9-7-10(18)17-11(9)8-5-3-2-4-6-8;1-2/h2-13,15,22,25H,14,16H2,1H3,(H,32,36);1-8H,9H2;2-6,9,11H,7H2,1H3,(H,16,19)(H,17,18);2H2,1H3/t22-,25+;;9-,11?;/m0.0./s1 |
| InChIKey | GSFZPYHRKLOTLH-HPPLSGEUSA-N |
| XLogP | 9.63 |
| TPSA | 169.27 Ų |
| H-Bond Donors | 4 |
| H-Bond Acceptors | 9 |
| Rotatable Bonds | 11 |
| Heavy Atoms | 75 |
| Complexity | — |
Lipinski Rule of Five
2 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 1143.97 |
| LogP ≤ 5 | 9.63 |
| H-Bond Donors ≤ 5 | 4 |
| H-Bond Acceptors ≤ 10 | 9 |
Computed Properties (RDKit)
| Structural Alerts | {'alert_name': 'iodine', 'substructure': 'N/A'} |
|---|
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158350406 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.